2. Fujiwara Y, Doki Y, Taniguchi H, et al. Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric Cancer 2007;10:197-204.10.1007/s10120-007-0436-5
3. Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. Cancer Treat Rev 2016;48:42-9.10.1016/j.ctrv.2016.06.007
4. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978-1984.10.1002/1097-0142(19840501)53:9<;1978::AID-CNCR2820530929>3.0.CO;2-1
5. de Waal Y, Thomas C, Oei A, et al. Secondary ovarian malignancies: Frequency, origin, and characteristics. Int J Gynecol Cancer 2009;19: 1160-65.10.1111/IGC.0b013e3181b33cce
6. Skírnisdóttir I, Garmo H and Holmberg L: Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: Occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007;105:166-71.10.1016/j.ygyno.2006.11.005
7. Moore RG, Chung M, Granai CO, et al: Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2004;93:87-91.10.1016/j.ygyno.2003.12.039
8. Turan T, Aykan B, Koc S, et all. Analysis of metastatic ovarian tumors from extragenital primary sites. Tumori 2006;92:491-5.10.1177/030089160609200605
9. Yada-Hashimoto N, Yamamoto T, Kamiura S, et al. Metastatic ovarian tumors: A review of 64 cases. Gynecol Oncol 2003;89:314-17.10.1016/S0090-8258(03)00075-1
11. Bang Y. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer 1999; 85:1490-99.10.1002/(SICI)1097-0142(19990401)85:7<;1490::AID-CNCR9>3.0.CO;2-G
12. Feng Q, Pei W, Zheng Z et al. Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis. Cancer Biol Med. 2013;10:86-91.
13. Kim W, Kim T, Kim S et al.The role of cytoreductive surgery for nongenital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol 2010; 149:97-101.10.1016/j.ejogrb.2009.11.011
14. Ulbright T, Roth L, Stehman F. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 1984;53:1164-74.10.1002/1097-0142(19840301)53:5<;1164::AID-CNCR2820530523>3.0.CO;2-4
15. Kobayashi O, Sugiyama Y, Cho H et al. Clinical and pathological study of gastric cancer with ovarian metastasis. Int J Clin Oncol 2003;8:67-71.10.1007/s101470300012
16. Miller B, Pittman B, Wan J et al. Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol 1997;66:368-71.10.1006/gyno.1997.4811
17. Rosa F, Marrelli D, Morgagni P et al. Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience. World J Surg 2016; 40:921-28.10.1007/s00268-015-3326-8
18. Skírnisdóttir I, Garmo H, Holmberg L. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: Occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007; 105:166-7.10.1016/j.ygyno.2006.11.005
19. Papakonstantinou E, Liapis A, Kairi-Vassilatou E et al. Virilizing ovarian Krukenberg tumor in a 27-year-old pregnant woman. A case report and literature review. Eur J Gynaecol Oncol 2011;32:331-3.
20. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30:277-99.10.1097/01.pas.0000190787.85024.cb
22. Jun S-Y, Park J. Metachronous Ovarian Metastases Following Resection of the Primary Gastric Cancer. J Gastric Cancer 2011;11: 31-7.10.5230/jgc.2011.11.1.31
23. Matsushita H, Watanabe K, Wakatsuki A. Metastatic gastric cancer to the female genital tract. Mol Clin Oncol. 2016;5:495-99.10.3892/mco.2016.1035510384527882232
24. Lu L, Shao Y, Hsu C et al. Metastasectomy of Krukenberg tumors may be associated with survivalbenefits in patients with metastatic gastric cancer. Anticancer Res. 2012;32:3397-401.
25. Cho JH, Lim JY, Choi AR et al. Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg. Cancer Res Treat 2015;47:697-705.10.4143/crt.2013.175461419525648093
26. Brieau B, Auzolle C, Pozet A, et al. Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study. Dig Liver Dis 2016;48:441-45.10.1016/j.dld.2015.12.01226775096
27. Wu XJ, Yuan P, Li ZY et al: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination. Tumour Biol. 2013;34:463-9.10.1007/s13277-012-0571-423108893